Gleb Andryianau

Gleb Andryianau is an accomplished professional in the field of medicinal chemistry and innovative materials science, currently serving as the R&D Director at FutureCeuticals since May 2022, focusing on the development of standardized materials through global R&D and manufacturing. As a co-founder and Principal Technology Consultant at BioSENS Labs since September 2020, Gleb Andryianau leads efforts in developing novel molecular detection methods tailored for Point-of-Care Testing. Previously, as a scientist at OncoArendi Therapeutics from May 2017 to August 2020, Gleb Andryianau contributed to the discovery of chitinase inhibitors and ligands for the chitinase-like YKL40 protein. Gleb Andryianau holds a Master of Science in Chemical Technology, specializing in Technology of Fine Chemicals, from Cracow University of Technology, graduated with honors in 2015.